The Cancer Diagnostics Market new Product Development Opportunites and Business Expansion Strategies for Instrument and Reagent Suppliers

Date: April 22, 2011
Pages: 1200
Price:
US$ 28,500.00 US$ 24,225.00
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C9B4CFA0812EN
Leaflet:

Download PDF Leaflet

The Cancer Diagnostics Market new Product Development Opportunites and Business Expansion Strategies for Instrument and Reagent Suppliers
This unique report contains information not available from any other source, such as:

1) sales and market shares of major suppliers by country;
2) volume and sales forecasts by procedure, market segment, and country;
3) specific new product development and business expansion opportunities for suppliers; and much more.

The 2009 edition of the report, "The Cancer Diagnostics Market: New Product Development and Business Strategies," is being updated by VENTURE PLANNING GROUP in order to assist current suppliers and companies planning to diversify into the diagnostics market in evaluating emerging opportunities in the dynamic and rapidly evolving cancer diagnostics field, and to help executives develop effective business, R&D and marketing strategies.

VPG’s market intelligence and technology assessment studies are based on interviews with clinical pathologists, laboratory directors, executives from leading diagnostic companies and start-up firms developing innovative products, university scientists, as well as experts from industry associations, venture capital firms and the investment banking community in the U.S., five major European countries and Japan.The market projections are also based on questionnaire responses received from hospitals, commercial/private laboratories, physician offices/group practices, cancer clinics and ambulatory care centers in seven countries.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product literature, patents, trade association surveys, government studies, marketing and technical meeting presentations, industry analyst reports, as well as VPG's proprietary data files was conducted.

This two-volume report contains over 1,200 pages, 450 tables and presents the following information:

MARKET SEGMENTATION ANALYSIS

Sales and market shares of major suppliers, by individual test and country.

Placements and total installed base of major analyzers used for cancer diagnostic testing by supplier and model.

Ten-year test volume and sales forecasts for over 40 major cancer diagnostic tests by country and market segment, including:
  • Hospitals
  • Commercial/Private Laboratories
  • Physician Offices/Group Practices
  • Cancer Clinics
  • Ambulatory Care Centers

Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country.

Cancer statistics, etiology and recent developments in the U.S., Japan and five major European countries.

CURRENT AND EMERGING PRODUCTS

Review of over 200 current and emerging cancer diagnostic tests, including:
  • Biochemical Markers
  • Oncogenes
  • Growth Factors
  • Hormones
  • Colony Stimulating Factors
  • Lymphokines
  • Immunohistochemical Stains, and others.

Analysis of nearly 30 major immunoassay analyzers used for cancer diagnostic testing, including their operating characteristics, features and selling prices.

TECHNOLOGY REVIEW

Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, computers, artificial intelligence, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing.

Review of competing/complementing technologies, including CT, MRI, NMR, PET and photonics spectroscopy.

Extensive listings of over 500 companies, universities and research centers developing new cancer diagnostic technologies, products and applications.

COMPETITIVE ASSESSMENTS

Extensive (up to 6 pages each) strategic assessments of over 70 major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

WORLDWIDE MARKET OVERVIEW

Estimated universe of laboratories performing cancer testing by country.
❍Ten-year test volume and sales projections by country.

BUSINESS OPPORTUNITIES AND STRATEGIC RECOMMENDATIONS

Specific new product development opportunities with potentially significant market appeal during the next ten years.
Design criteria for new products.
Alternative market penetration strategies.
Potential market entry barriers and risks.
I. INTRODUCTION

II.WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. CANCER STATISTICS AND ETIOLOGY
  1. Bladder
  2. Breast
  3. Cervical
  4. Colon and Rectum
  5. Endometrial
  6. Esophagus
  7. Head and Neck
  8. Leukemia
  9. Lung
  10. Lymphoma
  11. Oral
  12. Ovarian
  13. Prostate
  14. Renal Cell Carcinoma
  15. Skin
  16. Stomach
  17. Uterine
B. MAJOR CURRENT AND EMERGING CANCER DIAGNOSTIC TESTS
  1. Introduction
  2. Tumor Marker Classification
  3.ACTH
  4. AFP
  5. Beta-2 Microglobulin
  6. CA 15-3/27.29
  7. CA 19-9
  8. CA 125
  9. Calcitonin
  10. Carcinoembrionic Antigen (CEA)
  11. Estrogen and Progesterone Receptors
  12. Ferritin
  13. Gastrin
  14. Human Chorionic Gonadotropin (HCG)
  15. Insulin
  16. Lymphocytes CD4/CD8
  17. NSE
  18. Occult Blood
  19. Pap Smear/HPV
  20. Prostatic Acid Phosphatase (PAP)
  21. PSA (free & complexed)
  22. Squamus Cell Carcinoma Antigen
  23. TdT
  24. Thyroglobulin
  25. Tissue Polypeptide Antigen (TPA)
  26. Biochemical Markers
    ADA
    B-Protein
    PNP
    5'-Nucleotidase
  27. Oncogenes
    Abl/abl-bcr
    AIB1
    APC
    BAT 26
    BCL-2
    BCR-ABL
    B-raf
    BRCA
    CD44
    CDK
    C-abl
    C-fos
    C-myb
    C-myc
    CYCD1
    CYP-17
    DPC
    E-myc
    Erb-B
    HER-2/neu
    HPC1
    HSTF
    L-myc
    MET
    MSH
    NEU
    N-myc
    N-telopeptide
    PCA3
    PIK3CA
    PTI-1
    p10
    p40
    p51
    p53
    Ras
    Reg
    RET
    sFas
    Sis
    Src
  28. Polypeptide Growth Factors
    Basic Fibroblast Growth Factor
    Beta-TGF
    Cachectin (TNT)
    Calmodulin
    ECFR
    Nerve Growth Factor (NGF)
    Epidermal Growth Factor (EGF)
    Ornithine Decarboxylase
    Transferrin
    Transforming Growth Factor-Alpha
  29. Ectopic Hormones
  30. Colony Stimulating Factors
  31. Lymphokines
    Alpha-Interferon
    B-Cell Growth Factor (BCGF)
    Gamma-Interferon
    Interleukin-1 and 2
    Macrophage Activating Factor
  32. Immunohistochemical Stains
  33. Emerging Tumor Markers
    N-Acetylglucosamine
    Actin
    Alpha-Actin
    Angiogenin
    Angiostatin
    Antineuronal Antibodies
    7B2
    B72.3
    B-Protein
    Bax
    BCD-F9
    BLCA-4
    Blood Group Antigens A,B, H
    BTA
    CA 50
    CA 72-4/TAG-72
    CA 195
    CA-242
    CA-549
    Cadherin
    CAM 26
    CAR-3
    CD 105
    Cathepsin-D
    Chromogranin A and B
    Cluster 1 Antigen
    Cluster-5/5A Antigen
    COX Antigen
    CTA
    CU18
    Cyclin
    DR-70
    DU-PAN-2
    Endometrial Bleeding Associated Factor
    Endostatin
    Epithelial Membrane Antigen
    FDP
    Feulgen Hydrolysis
    Fibronectin
    FSH
    (1->3)-L-fucosyltransferase
    Gastrin-Releasing Peptide (GRP)
    GDCFP-15
    Glucagon
    Glycoamines
    H23
    HAAH
    hk3
    HPA
    HSP27
    Human Carcinoma Antigen
    ICAM
    Intermediate Filaments
      - Cytokeratins/CK18/Cyfra 21-1
      - Desmin
      - Gliofibrillary Acid Protein
      - Neurofilaments
      - Vimentin
    KA 93
    Kallikrein
    Kinases
    KP16D3
    LAI
    Leukocyte Common Antigen
    Lewis Antigens
    Lysophosphatidic Acid
    Ma 695/Ma 552
    MABDF3
    MAG
    ME1
    Minactivin
    MN/CA9
    MSA
    Mucin Cancer Antigen
    Multiple Tumor Suppressor 1
    Myosin
    NEA-130
    NMP22
    Nucleolar
    OA-519
    Opiod Peptides
    P-glycoprotein
    Pancreatic Oncofetal Antigen
    Parathyroid Hormone
    Placental Lactogen
    PR92
    Proliferative Index, Ki-67
    Px
    RB Inactivation/Deletion
    Ret
    S-100 Protein
    SCCL 175
    Selectin
    Serotonin
    Sialic Acid
    Sialyl SSEA-1/SLX
    SN10
    Somatostatin
    TA-90
    TABA
    Tachykinin
    TAG 12
    TPS
    Troponin
    Tubulin
    VCAM
    VEGF
    Villen
    White Blood Cell Markers
C. INSTRUMENTATION REVIEW AND MARKET NEEDS
    Abbott Architect
    Abbott AxSYM
    Abbott IMx
    Amersham Amerlite
    Bayer ACS: 180
    Bayer ADVIA Centaur
    Bayer Immuno 1
    Beckman Coulter Access
    bioMerieux Vidas Series
    Biotrol System 7000
    Dade Behring Dimension
    DPC Immulite
    DiaSorin ETI-Max
    Ortho-Clinical Diagnostics Vitros
    Olympus PK Series
    Roche Elecsys
    Roche Modular
    Tosoh AIA Series
D. CURRENT AND EMERGING TECHNOLOGIES
  1. Monoclonal and Polyclonal Antibodies
  2. Immunoassays
    a. Technological Principle
    b. Radioimmunoassays
    c. Enzyme Immunoassays
      Overview
      ELISA
      Immunofiltration
      Particle-Membrane Capture
      Enzyme Amplification
    d. Fluorescent Immunoassays
    e. Luminescence
      Chemiluminescence
      Bioluminescence
  3. Molecular Diagnostics
    a. Technology Overview
    b. Amplification Methods
      PCR
        - DAP-PCR
        - Immuno-PCR
        - QC-PCR
      CAR
      DNA
      HPA
      LCR
      NASBA
      QBR
      SDA
      3SR, and others
  4. Biochips/Microarrays
  5. Chromosome Analysis
    a. Chronic Myelogenous Leukemia
    b. Acute Myeloid Leukemia
    c. Acute Lymphoblastic Leukemia
    d. Malignant Lymphomas
    e. Chronic Lymphocytic Leukemia
    f. Solid Cancers
    g. Chromosomal Translocation and Oncogenes
  6. Microcomputers and Automation
  7. Artificial Intelligence
  8. Flow Cytometry
  9. Biosensors
E. COMPETING/COMPLEMENTING TECHNOLOGIES
  1. CT
  2. MRI
  3. NMR
  4. PET
  5. Photonics Spectroscopy
F. WORLDWIDE BUSINESS ENVIRONMENT
  1. Market Structure
  2. Market Size and Growth
G. PERSONAL TESTING

III. FRANCE

A. EXECUTIVE SUMMARY
B. BUSINESS ENVIRONMENT
C. MARKET STRUCTURE
D. MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES, INSTRUMENT PLACEMENTS AND MARKET SHARES

IV. GERMANY

A. EXECUTIVE SUMMARY
B. BUSINESS ENVIRONMENT
C. MARKET STRUCTURE
D. MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES, INSTRUMENT PLACEMENTS AND MARKET SHARES

V. ITALY

A. EXECUTIVE SUMMARY
B. BUSINESS ENVIRONMENT
C. MARKET STRUCTURE
D. MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES, INSTRUMENT PLACEMENTS AND MARKET SHARES

VI. JAPAN

A. EXECUTIVE SUMMARY
B. BUSINESS ENVIRONMENT
C. MARKET STRUCTURE
D. MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES, INSTRUMENT PLACEMENTS AND MARKET SHARES

VII. SPAIN

A. EXECUTIVE SUMMARY
B. BUSINESS ENVIRONMENT
C. MARKET STRUCTURE
D. MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES, INSTRUMENT PLACEMENTS AND MARKET SHARES

VIII. U.K.

A. EXECUTIVE SUMMARY
B. BUSINESS ENVIRONMENT
C. MARKET STRUCTURE
D. MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES, INSTRUMENT PLACEMENTS AND MARKET SHARES

IX. U.S.A.

A. EXECUTIVE SUMMARY
B. BUSINESS ENVIRONMENT
  1. Health Care Expenditures
  2. Cost Consciousness
  3. Reimbursement
  4. Industry Consolidation
  5. Managed Care
    a. PPOs
    b. HMOs
  6. Hospitals
  7. Admissions
  8. Length of Stay
  9. Industry Diversification
  10. Physician Demographics
  11. Population Aging
    a. Chronic Illnesses
    b. Disease Incidence
    c. Susceptibility to Iatrogenesis
    d. Multiple Illnesses
  12. Laboratory Regulations
  13. FDA Reform
C. MARKET STRUCTURE
  1. Centralized Testing
    a. Hospitals
    b. Commercial/Private Laboratories
  2. POT/Decentralized Testing
    a. Physician Offices
    b. Cancer Clinics
    c. Other Locations
D. MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES, INSTRUMENT PLACEMENTS AND MARKET SHARES

X. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. REAGENT KITS AND TEST SYSTEMS/PANELS
B. INSTRUMENTATION
C. COMPUTERS, SOFTWARE AND AUTOMATION
D.AUXILLARY PRODUCTS

XI. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

XII. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. INTERNAL DEVELOPMENT
B. COLLABORATIVE ARRANGEMENTS
C. UNIVERSITY CONTRACTS
D. DISTRIBUTION STRATEGIES
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation Factors

XIII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. MARKET MATURITY
B. COST CONTAINMENT
C. COMPETITION
D. TECHNOLOGICAL EDGE AND LIMITATIONS
E. PATENT PROTECTION
F. REGULATORY CONSTRAINTS
G. DECENTRALIZED TESTING MARKET CHALLENGES

XIV. COMPETITIVE PROFILES

    Abbott
    AdnaGen
    Agensys
    Altana
    Ambrilia Biopharma
    AMDL
    BD
    Beckman Coulter
    Biofield
    Biomedical Diagnostics
    bioMerieux
    Bio-Rad
    Biotrol/B. Braun
    CeMines
    Cepheid
    CIS/BIO
    Cliniqa
    Correlogic Systems
    Cytyc
    Daiichi
    DakoCytomation
    diaDexus
    DiagnoCure
    Diagnostic Systems
    Dianon
    DiaSorin
    Digene
    Eiken
    Enterix
    Enzo Biochem
    Epigenomics
    Exact Sciences
    Fujirebio
    Gen-Probe
    Gene Logic
    Green Cross
    Grifols-Quest
    Guided Therapeutics
    Ibex Technologies
    Immnunicon
    Ipsogen
    Kyowa Medex
    Matritech
    Molecular Diagnostics
    Myriad Genetics
    Nippon Flour Mills
    OncoLab
    Ortho-Clinical Diagnostics
    Panacea Pharmaceuticals
    Polartechnics
    Polymedco
    PreMD
    Quest Diagnostics Nichols Institute
    Roche Diagnostics
    Scantibodies
    Siemens
    Targeted Diagnostics
    Tosoh
    Trylon
    Wako Chemicals
    Worldwide Medical
    Zila, and others

XV. APPENDIXES

APPENDIX I: MAJOR COMPANIES DEVELOPING OR MARKETING CANCER DIAGNOSTIC REAGENTS AND INSTRUMENTS
APPENDIX II: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING CANCER DIAGNOSTIC TECHNOLOGIES AND APPLICATIONS
APPENDIX III: ASSUMED CURRENCY EXCHANGE RATES THE CANCER DIAGNOSTICS MARKET: US, EUROPE, JAPAN
Emerging Opportunities and Business Expansion Strategies

LIST OF TABLES

Tumor Marker Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Executive Summary Table: France, Total Cancer Diagnostic Test Volume and Sales Forecast by Market Segment
France, Estimated Cancer Death Rates Per 100,000 Population
France, Laboratories Performing Tumor Marker Tests by Market Segment
France, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
France, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
France, Total Tumor Marker Test Volume Forecast by Market Segment
France, All Market Segments Major Tumor Marker Test Volume Forecast
France, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
France, Commercial/Private Laboratories Marker Test Volume Forecast
France, Total Tumor Marker Sales Major Tumor Forecast by Market Segment
France, All Market Segments Major Tumor Marker Sales Forecast by Test
France, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
France, Commercial/Private Laboratories Cancer Diagnostics Market Forecast by Test
France, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
France, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
France, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
France, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
France, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market
France, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
France, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
France, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
France, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
France, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
France, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
France, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
France, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
France, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
France, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
France, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
France, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
France, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
France, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment
France, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
France, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
France, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
France, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
France, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
France, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
France, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
France, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
France, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
France, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
France, S-100 Protein Test Volume and Sales Diagnostics Sales Forecast by Market Segment
France, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
France, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
France, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
France, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
France, Thymidine Kinase Test Volume And Diagnostics Sales Forecast by Market Segment
France, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
France, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
France, Total Tumor Marker Sales By Major Suppliers
France, AFP Testing Market Diagnostics Sales by Major Supplier
France, CA 15-3 Testing Market Diagnostics Sales by Major Supplier
France, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
France, CA 125 Testing Market Diagnostics Sales by Major Supplier
France, CEA Testing Market Diagnostics Sales by Major Supplier
France, NSE Testing Market Diagnostics Sales by Major Supplier
France, PAP Testing Market Diagnostics Sales by Major Supplier
France, PSA Testing Market Diagnostics Sales by Major Supplier
France, Tumor Marker Testing Instrumentation Major Systems Estimated Placements and Installed Base by Supplier and Model
Executive Summary Table: Germany, Total Tumor Marker Test Volume and Sales Forecast By Market Segment
Germany, Estimated Cancer Death Rates Per 100,000 Population
Germany, Laboratories Performing Tumor Marker Tests by Market Segment
Germany, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Germany, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
Germany, Total Tumor Marker Test Volume Forecast by Market Segment
Germany, All Market Segments, Major Tumor Marker Test Volume Forecast
Germany, Hospital Laboratories, Major Tumor Marker Test Volume Forecast by Test
Germany, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
Germany, Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
Germany, Total Tumor Marker Sales Forecast by Market Segment
Germany, All Market Segments Major Tumor Marker Sales Forecast by Test
Germany, Hospital Laboratories, Major Tumor Marker Sales Forecast by Test
Germany, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Germany, Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
Germany, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecast by Market Segment
Germany, CA-15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, CA-19 Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Calcitonin Test Volume and Diagnostic Sales Forecast by Market Segment
Germany, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
Germany, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, HCG, Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Pap Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
Germany, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Serotonin Test Volume and Diagnostics Sales Forecast by Mar Segment
Germany, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
Germany, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Total Tumor Marker Sales By Major Supplier
Germany, AFP Testing Market Diagnostics Sales by Major Supplier
Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier
Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
Germany, CEA Testing Market Diagnostics Sales by Major Supplier
Germany, PSA Testing Market Diagnostics Sales by Major Supplier
Germany, Tumor Marker Testing Instrumentation Major Systems Estimated Placements and Installed Base By Supplier and Model
Executive Summary Table: Italy, Total Tumor Marker Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Estimated Cancer Death Rates Per 100,000 Population
Italy, Laboratories Performing Tumor Marker Tests by Market Segment
Italy, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Italy, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
Italy, Total Tumor Marker Test Volume Forecast by Market Segment
Italy, All Market Segments Major Cancer Diagnostic Test Volume Forecast
Italy, Hospital Laboratories Major Tumor Marker Test Volume Forecast
Italy, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
Italy, Total Tumor Marker Test Market Forecast by Market Segment
Italy, All Market Segments Major Tumor Marker Sales Forecast by Test
Italy, Hospital Laboratories Major Tumor Marker Forecast by Test
Italy, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Italy, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecast by Market Segment
Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, CA-19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Colon Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
Italy, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment
Italy, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, S-100 Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Total Tumor Markers Sales by Major Suppliers
Italy, AFP Testing Market Diagnostics Sales by Major Supplier
Italy, CEA Testing Market Diagnostics Sales by Major Supplier
Italy, PSA Testing Market Diagnostics Sales by Major Supplier
Italy, Tumor Marker Testing Instrumentation Major Non-isotopic Systems Estimated Installed Base by Supplier and Model
Executive Summary Table: Japan, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
Japan, Estimated Cancer Death Rates Per 100,000 Population
Japan, Laboratories Performing Tumor Marker Tests by Market Segment
Japan, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Commercial/Private Laboratories Performing Tumor Marker Tests By Annual Test Volume
Japan, Total Tumor Marker Testing Volume Forecast by Market Segment
Japan, All Market Segments Major Tumor Marker Test Volume Forecast
Japan, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
Japan, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
Japan, Total Tumor Marker Sales Forecast by Market Segment
Japan, All Market Segments Major Tumor Marker Sales Forecast by Test
Japan, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
Japan, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Japan, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
Japan, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, TPA, Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Total Tumor Marker Sales by Major Suppliers
Japan, AFP Testing Market Diagnostics Sales by Major Supplier
Japan, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Japan, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
Japan, CA 125 Testing Market Diagnostics Sales by Major Supplier
Japan, Calcitonin Testing Market Diagnostics Sales by Major Supplier
Japan, CEA Testing Market Diagnostics Sales by Major Supplier
Japan, NSE Testing Market Diagnostics Sales by Major Supplier
Japan, PAP Testing Market Diagnostics Sales by Major Supplier
Japan, PSA Testing Market Diagnostics Sales by Major Supplier
Japan, Tumor Marker Testing Instrumentation, Major Systems Estimated Placements and Installed Base By Supplier and Model
Executive Summary Table: Spain, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
Spain, Estimated Cancer Death Rates Per 100,000 Population
Spain, Laboratories Performing Tumor Marker Tests by Market Segment
Spain, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Spain, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
Spain, Total Tumor Marker Test Volume Forecast by Market Segment
Spain, All Market Segment Major Cancer Diagnostic Test Volume Forecast
Spain, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecast by Test
Spain, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
Spain, Total Tumor Marker Sales Forecast by Market Segment
Spain, All Market Segments Major Tumor Marker Sales Forecast by Test
Spain, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
Spain, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Spain, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CA 15-3 Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Parathyroid Hormone Test Volume And Diagnostics Sales Forecast by Market Segment
Spain, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, S-100 Protein Test Volume And Diagnostics Sales Forecast by MarketSegment
Spain, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Total Tumor Marker Sales by Major Suppliers
Spain, AFP Testing Market Diagnostics Sales by Major Supplier
Spain, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Spain, 19-9 Testing Market Diagnostics Sales by Major Supplier
Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier
Spain, CEA Testing Market Diagnostics Sales by Major Supplier
Spain, PSA Testing Market Diagnostics Sales by Major Supplier
Spain, Tumor Marker Testing Instrumentation Major Systems Estimated Placements and Installed Base by Supplier and Model
Executive Summary Table: U.K., Total Tumor Marker Test Volume and Sales Forecast by Market Segment
U.K., Estimated Cancer Death Rates Per 100,000 Population
U.K., Laboratories Performing Tumor Marker Tests by Market Segment
U.K., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
U.K., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume
U.K., Total Tumor Marker Testing Volume Forecast by Market Segment
U.K., All Market Segments Major Tumor Marker Test Volume Forecast
U.K., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
U.K., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
U.K., Total Tumor Marker Sales Forecast by Market Segment
U.K., All Market Segments Major Tumor Marker Sales Forecast by Test
U.K., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
U.K., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
U.K., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., CEA Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Colon-Specific Antigen Test Volume And Diagnostics Sales by Market Segment
U.K., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Total Tumor Marker Sales and Market Shares Forecast
U.K., CEA Testing Market Diagnostics Sales by Major Supplier
U.K., PSA Testing Market Diagnostics Sales by Major Supplier
U.K., Tumor Marker Testing Instrumentation Major Systems Estimated Placements and Installed Base By Supplier and Model
Executive Summary Table: U.S., Total Tumor Marker Test Volume and Sales Forecast by Market Segment
U.S., Estimated New Cancer Cases and Deaths
U.S., Estimated Cancer Death Rates Per 100,000 Population
U.S., Laboratories Performing Tumor Marker Tests by Market Segment
U.S., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
U.S., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume
U.S., Physician Office Laboratories Performing Tumor Marker Tests by Practice Size
U.S., Total Tumor Marker Test Volume Forecast by Market Segment-201
U.S., All Market Segments Major Tumor Marker Test Volume Forecast
U.S., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
U.S., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
U.S., Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
U.S., Cancer Clinics Major Tumor Marker Test Volume Forecast by Test
U.S., Total Tumor Marker Sales Forecast by Market Segment
U.S., All Market Segment Major Tumor Marker Sales Forecast by Test
U.S., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
U.S., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
U.S., Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
U.S., Cancer Clinics Major Tumor Marker Sales Forecast by Test
U.S., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., CEA Test Volume and Diagnostics Sales by Market Segment
U.S., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Colon-specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Total Tumor Marker Sales By Major Supplier
U.S., AFP Testing Market Diagnostics Sales by Major Supplier
U.S., CA 125 Testing Market Diagnostics Sales by Major Supplier
U.S., CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
U.S., CEA Testing Market Diagnostics Sales by Major Supplier
U.S., Ferritin Testing Market Diagnostics Sales by Major Supplier
U.S., HCG Testing Market Diagnostics Sales by Major Supplier
U.S., Insulin Testing Market Diagnostics Sales by Major Supplier
U.S., PAP Testing Market Diagnostics Sales by Major Supplier
U.S., PSA Testing Market Diagnostics Sales by Major Supplier
U.S., Tumor Marker Testing Instrumentation Major Systems Estimated Placements and Installed Base by Supplier and Model
Skip to top


Ask Your Question

The Cancer Diagnostics Market new Product Development Opportunites and Business Expansion Strategies for Instrument and Reagent Suppliers
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: